Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Revaccination study of low-dose AS03-adjuvanted influenza vaccine versus Fluarix in adults previously vaccinated in FLU-LD-004
2007-002783-10Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of AS03-adjuvanted low-dose influenza vaccine and Fluarix in influenza (2 arms), sponsored by GSK. Primary endpoints: Solicited local and general signs and symptoms and Safety and reactogenicity during entire study period. Started Aug 2007; status: completed.
02
Drugs
AS03-adjuvanted low-dose influenza vaccineFluarix
03
Conditions
influenza
Beyond the preview
Go deeper on 2007-002783-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002783-10.